Last 12 months
Inside the activity.
0 purchase rows · 39 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 8 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 19, 2021 Filed Jul 22, 2021 00:30 UTC |
Mathew Aby J.Exec VP & Chief Scientific Off
|
SaleCommon Stock | 10,000 | $43.85 | $438,500.00 |
DisclosureSEC source: 0001437749-21-017325 · rdgdoc.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,589 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.43 to $44.52, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 19, 2021 Filed Jul 22, 2021 00:30 UTC |
Mathew Aby J.Exec VP & Chief Scientific Off
|
Exercise / conversionCommon Stock | 10,000 | $1.64 | $16,400.00 |
DisclosureSEC source: 0001437749-21-017325 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,160 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-21-017168 · rdgdoc.xml · derivative · entry 6 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,280 Underlying: Common Stock · 6,160 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 6,160 | $44.04 | $271,286.40 |
DisclosureSEC source: 0001437749-21-017168 · rdgdoc.xml · nonDerivative · entry 4 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,064 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.62 to $44.78 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionCommon Stock | 6,160 | $1.64 | $10,102.40 |
DisclosureSEC source: 0001437749-21-017168 · rdgdoc.xml · nonDerivative · entry 3 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 15, 2021 Filed Jul 17, 2021 00:00 UTC |
Hinson Andrew GDirector
|
SaleCommon Stock | 2,500 | $44.44 | $111,100.00 |
DisclosureSEC source: 0001437749-21-017103 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,175 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,165 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-21-017168 · rdgdoc.xml · derivative · entry 5 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,440 Underlying: Common Stock · 6,165 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 6,165 | $42.74 | $263,492.10 |
DisclosureSEC source: 0001437749-21-017168 · rdgdoc.xml · nonDerivative · entry 2 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,064 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.15 to $43.78 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2021 Filed Jul 20, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionCommon Stock | 6,165 | $1.64 | $10,110.60 |
DisclosureSEC source: 0001437749-21-017168 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 12, 2021 Filed Jul 15, 2021 00:02 UTC |
Hinson Andrew GDirector
|
GrantCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-21-016944 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,675 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests on the twelve-month anniversary of the grant date. Read SEC document |
| July 12, 2021 Filed Jul 15, 2021 00:01 UTC |
Schick Joseph CDirector
|
GrantCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-21-016943 · rdgdoc.xml · nonDerivative · entry 1 Schick Joseph C · CIK 0001592238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,375 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests on the twelve-month anniversary of the grant date. Read SEC document |
| July 12, 2021 Filed Jul 15, 2021 00:00 UTC |
COHEN RAYMOND WDirector
|
GrantCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-21-016942 · rdgdoc.xml · nonDerivative · entry 1 COHEN RAYMOND W · CIK 0001258288 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,763 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 01:02 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 11,464 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-21-016690 · rdgdoc.xml · derivative · entry 6 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,613 Underlying: Common Stock · 11,464 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares vested on March 8, 2019. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 01:02 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 11,464 | $46.15 | $529,063.60 |
DisclosureSEC source: 0001437749-21-016690 · rdgdoc.xml · nonDerivative · entry 4 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,310 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.15 to $47.93, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 08, 2021 Filed Jul 9, 2021 01:02 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionCommon Stock | 11,464 | $1.64 | $18,800.96 |
DisclosureSEC source: 0001437749-21-016690 · rdgdoc.xml · nonDerivative · entry 3 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 08, 2021 Filed Jul 10, 2021 00:00 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 140 | $45.72 | $6,400.80 |
DisclosureSEC source: 0001437749-21-016741 · rdgdoc.xml · nonDerivative · entry 2 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,905 F1 · shares: The sales reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| July 08, 2021 Filed Jul 10, 2021 00:00 UTC |
Schulz MarcusChief Revenue Officer
|
SaleCommon Stock | 100 | $45.75 | $4,575.00 |
DisclosureSEC source: 0001437749-21-016741 · rdgdoc.xml · nonDerivative · entry 1 Schulz Marcus · CIK 0001812702 · Chief Revenue Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,045 F1 · shares: The sales reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| July 06, 2021 Filed Jul 9, 2021 01:02 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 11,461 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-21-016690 · rdgdoc.xml · derivative · entry 5 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,077 Underlying: Common Stock · 11,461 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares vested on March 8, 2019. Read SEC document |
| July 06, 2021 Filed Jul 9, 2021 01:02 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 11,461 | $46.28 | $530,415.08 |
DisclosureSEC source: 0001437749-21-016690 · rdgdoc.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,310 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.22 to $46.80, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 06, 2021 Filed Jul 9, 2021 01:02 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionCommon Stock | 11,461 | $1.64 | $18,796.04 |
DisclosureSEC source: 0001437749-21-016690 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 29, 2021 Filed Jul 2, 2021 00:32 UTC |
Mathew Aby J.Exec VP & Chief Scientific Off
|
SaleCommon Stock | 715 | $43.75 | $31,281.25 |
DisclosureSEC source: 0001437749-21-016269 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,589 F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 29, 2021 Filed Jul 2, 2021 00:31 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 607 | $43.75 | $26,556.25 |
DisclosureSEC source: 0001437749-21-016268 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,777 F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 29, 2021 Filed Jul 2, 2021 00:31 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 902 | $43.75 | $39,462.50 |
DisclosureSEC source: 0001437749-21-016267 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 269,310 F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 29, 2021 Filed Jul 2, 2021 00:31 UTC | SaleCommon Stock | 685 | $43.75 | $29,968.75 |
DisclosureSEC source: 0001437749-21-016266 · rdgdoc.xml · nonDerivative · entry 1 DE GREEF RODERICK · CIK 0001241181 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,853 F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
|
| June 29, 2021 Filed Jul 2, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 502 | $43.75 | $21,962.50 |
DisclosureSEC source: 0001437749-21-016265 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,064 F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 00:30 UTC |
Foster Karen A.Chief Quality Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 16,332 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-21-015404 · rdgdoc.xml · derivative · entry 3 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,661 Underlying: Common Stock · 16,332 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 163,323 shares of common stock which vested in two equal installments on March 8, 2018 and March 8, 2019. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 00:30 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 16,332 | $42.79 | $698,846.28 |
DisclosureSEC source: 0001437749-21-015404 · rdgdoc.xml · nonDerivative · entry 2 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,384 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.40 to $43.22 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 00:30 UTC |
Foster Karen A.Chief Quality Officer
|
Exercise / conversionCommon Stock | 16,332 | $1.64 | $26,784.48 |
DisclosureSEC source: 0001437749-21-015404 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 6,160 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-21-014985 · rdgdoc.xml · derivative · entry 6 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,605 Underlying: Common Stock · 6,160 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 6,160 | $39.26 | $241,841.60 |
DisclosureSEC source: 0001437749-21-014985 · rdgdoc.xml · nonDerivative · entry 4 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,566 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.92 to $39.70 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionCommon Stock | 6,160 | $1.64 | $10,102.40 |
DisclosureSEC source: 0001437749-21-014985 · rdgdoc.xml · nonDerivative · entry 3 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 00:30 UTC |
Mathew Aby J.Exec VP & Chief Scientific Off
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-21-014984 · rdgdoc.xml · derivative · entry 6 Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,707 Underlying: Common Stock · 10,000 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 197,707 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 00:30 UTC |
Mathew Aby J.Exec VP & Chief Scientific Off
|
SaleCommon Stock | 10,000 | $39.27 | $392,700.00 |
DisclosureSEC source: 0001437749-21-014984 · rdgdoc.xml · nonDerivative · entry 4 Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,304 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.95 to $39.69, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 00:30 UTC |
Mathew Aby J.Exec VP & Chief Scientific Off
|
Exercise / conversionCommon Stock | 10,000 | $1.64 | $16,400.00 |
DisclosureSEC source: 0001437749-21-014984 · rdgdoc.xml · nonDerivative · entry 3 Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 6,160 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-21-014985 · rdgdoc.xml · derivative · entry 5 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,765 Underlying: Common Stock · 6,160 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 123,209 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
SaleCommon Stock | 6,160 | $39.38 | $242,580.80 |
DisclosureSEC source: 0001437749-21-014985 · rdgdoc.xml · nonDerivative · entry 2 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,566 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.55 to $39.80 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 00:30 UTC |
Berard ToddChief Marketing Officer
|
Exercise / conversionCommon Stock | 6,160 | $1.64 | $10,102.40 |
DisclosureSEC source: 0001437749-21-014985 · rdgdoc.xml · nonDerivative · entry 1 Berard Todd · CIK 0001633186 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,726 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 00:30 UTC |
Hinson Andrew GDirector
|
SaleCommon Stock | 2,500 | $38.35 | $95,875.00 |
DisclosureSEC source: 0001437749-21-015121 · rdgdoc.xml · nonDerivative · entry 1 Hinson Andrew G · CIK 0001389410 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,675 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 00:30 UTC |
Mathew Aby J.Exec VP & Chief Scientific Off
|
Exercise / conversionEmployee Stock Option · Derivative | 10,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-21-014984 · rdgdoc.xml · derivative · entry 5 Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,707 Underlying: Common Stock · 10,000 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: On December 20, 2016, the reporting person was granted an option to purchase 197,707 shares of common stock which vested in two equal annual installments on March 8, 2018 and March 8, 2019. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 00:30 UTC |
Mathew Aby J.Exec VP & Chief Scientific Off
|
SaleCommon Stock | 10,000 | $38.90 | $389,000.00 |
DisclosureSEC source: 0001437749-21-014984 · rdgdoc.xml · nonDerivative · entry 2 Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,304 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.40 to $39.37, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 00:30 UTC |
Mathew Aby J.Exec VP & Chief Scientific Off
|
Exercise / conversionCommon Stock | 10,000 | $1.64 | $16,400.00 |
DisclosureSEC source: 0001437749-21-014984 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 00:31 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 11,461 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-21-014534 · rdgdoc.xml · derivative · entry 6 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,538 Underlying: Common Stock · 11,461 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares vested on March 8, 2019. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 00:31 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 11,461 | $36.47 | $417,982.67 |
DisclosureSEC source: 0001437749-21-014534 · rdgdoc.xml · nonDerivative · entry 4 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,212 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.85 to $36.87, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 10, 2021 Filed Jun 11, 2021 00:31 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionCommon Stock | 11,461 | $1.64 | $18,796.04 |
DisclosureSEC source: 0001437749-21-014534 · rdgdoc.xml · nonDerivative · entry 3 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2021 Filed Jun 11, 2021 00:31 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionEmployee Stock Option · Derivative | 11,461 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001437749-21-014534 · rdgdoc.xml · derivative · entry 5 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,999 Underlying: Common Stock · 11,461 shares Expires 2021-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested in two equal annual installments based on the registrant's satisfaction of certain performance criteria for the fiscal year ending December 2017. The performance criteria for 2017 were met, resulting in vesting of the option as follows: 114,613 shares vested on March 8, 2018 and 114,613 shares vested on March 8, 2019. Read SEC document |
| June 08, 2021 Filed Jun 11, 2021 00:31 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 11,461 | $35.54 | $407,323.94 |
DisclosureSEC source: 0001437749-21-014534 · rdgdoc.xml · nonDerivative · entry 2 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,212 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.30 to $36.33, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 08, 2021 Filed Jun 11, 2021 00:31 UTC |
Rice MichaelDirector · CEO
|
Exercise / conversionCommon Stock | 11,461 | $1.64 | $18,796.04 |
DisclosureSEC source: 0001437749-21-014534 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 28, 2021 Filed Jun 3, 2021 00:31 UTC |
Rice MichaelDirector · CEO
|
SaleCommon Stock | 802 | $33.87 | $27,163.74 |
DisclosureSEC source: 0001437749-21-014006 · rdgdoc.xml · nonDerivative · entry 1 Rice Michael · CIK 0001389512 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,212 F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 28, 2021 Filed Jun 3, 2021 00:31 UTC |
Mathew Aby J.Exec VP & Chief Scientific Off
|
SaleCommon Stock | 375 | $33.87 | $12,701.25 |
DisclosureSEC source: 0001437749-21-014005 · rdgdoc.xml · nonDerivative · entry 1 Mathew Aby J. · CIK 0001556355 · Exec VP & Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,304 F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
| May 28, 2021 Filed Jun 3, 2021 00:30 UTC |
Foster Karen A.Chief Quality Officer
|
SaleCommon Stock | 264 | $33.87 | $8,941.68 |
DisclosureSEC source: 0001437749-21-014004 · rdgdoc.xml · nonDerivative · entry 1 Foster Karen A. · CIK 0001683151 · Chief Quality Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,384 F1 · kind: The sale reported herein was made by the issuer to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.